BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 12429635)

  • 1. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
    Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
    J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
    Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
    Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
    Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
    Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
    Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
    Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
    Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
    Judkins AR; Mauger J; Ht A; Rorke LB; Biegel JA
    Am J Surg Pathol; 2004 May; 28(5):644-50. PubMed ID: 15105654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.
    Biegel JA; Fogelgren B; Zhou JY; James CD; Janss AJ; Allen JC; Zagzag D; Raffel C; Rorke LB
    Clin Cancer Res; 2000 Jul; 6(7):2759-63. PubMed ID: 10914721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors.
    Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
    Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of atypical teratoid/rhabdoid tumor.
    Biegel JA
    Neurosurg Focus; 2006 Jan; 20(1):E11. PubMed ID: 16459991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
    Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA
    Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
    Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
    Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.
    Raisanen J; Biegel JA; Hatanpaa KJ; Judkins A; White CL; Perry A
    Brain Pathol; 2005 Jan; 15(1):23-8. PubMed ID: 15779233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
    J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.